---
title: "BeiGene to Invest $19.5 Million in Bravera’s Series A Round"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305654310.md"
description: "According to ChainCatcher, BeiGene’s subsidiary BeiGene Switzerland plans to invest $19.5 million in cash and convert $500,000 in SAFE interests into Series A preferred shares. After the transaction, it will hold a 9.477% stake in Bravera."
datetime: "2026-11-16T10:20:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305654310.md)
  - [en](https://longbridge.com/en/news/305654310.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305654310.md)
generator: "portal-rs"
---

# BeiGene to Invest $19.5 Million in Bravera’s Series A Round

According to ChainCatcher, BeiGene’s subsidiary BeiGene Switzerland plans to invest $19.5 million in cash and convert $500,000 in SAFE interests into Series A preferred shares. After the transaction, it will hold a 9.477% stake in Bravera.

### Related Stocks

- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)

## Related News & Research

- [BeOne Medicines: Five solid-tumor programs advance as strong cash flow funds continued pipeline investment](https://longbridge.com/en/news/305810947.md)
- [BeOne commits $3M to expand CLL Society patient education pact](https://longbridge.com/en/news/305853990.md)
- [BeOne Medicines (ONC) Priority Review And Earnings Put Valuation Back In Focus](https://longbridge.com/en/news/304861942.md)
- [Why BeOne Medicines Stock Is In Focus After Earnings Beat And Raised Guidance](https://longbridge.com/en/news/304730912.md)
- [BeOne stock breaks out with visions of 177% earnings growth. This telltale clue bodes well.](https://longbridge.com/en/news/302773305.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**